$CBIS a U.S. company specializing in the development of cannabis-based medicines, is set to participate in the Global Health Catalyst (GHC) Summit at Harvard Medical School on April 28-30, 2017. Information on the GHC Summit is available at
http://www.globalhealthcatalystsummit.org.
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!